A detailed history of Oliver Lagore Vanvalin Investment Group transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Oliver Lagore Vanvalin Investment Group holds 80 shares of PCVX stock, worth $5,511. This represents 0.0% of its overall portfolio holdings.

Number of Shares
80
Previous 121 33.88%
Holding current value
$5,511
Previous $9,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$70.52 - $117.12 $2,891 - $4,801
-41 Reduced 33.88%
80 $9,000
Q2 2024

Aug 15, 2024

SELL
$60.06 - $78.77 $3,183 - $4,174
-53 Reduced 30.46%
121 $9,000
Q1 2024

May 15, 2024

SELL
$59.79 - $81.05 $6,576 - $8,915
-110 Reduced 38.73%
174 $11,000
Q4 2023

Jan 31, 2024

BUY
$45.35 - $63.41 $5,578 - $7,799
123 Added 76.4%
284 $17,000
Q3 2023

Nov 09, 2023

SELL
$46.0 - $53.1 $1,104 - $1,274
-24 Reduced 12.97%
161 $8,000
Q2 2023

Aug 08, 2023

BUY
$34.66 - $54.07 $6,412 - $10,002
185 New
185 $9,000

Others Institutions Holding PCVX

About Vaxcyte, Inc.


  • Ticker PCVX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,315,100
  • Market Cap $4.09B
  • Description
  • Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...
More about PCVX
Track This Portfolio

Track Oliver Lagore Vanvalin Investment Group Portfolio

Follow Oliver Lagore Vanvalin Investment Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oliver Lagore Vanvalin Investment Group, based on Form 13F filings with the SEC.

News

Stay updated on Oliver Lagore Vanvalin Investment Group with notifications on news.